CELLTRION, INC. Financial comparisons Celltrion, Inc.
Equities
A068270
KR7068270008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191,200.00 KRW | +1.70% |
|
-5.81% | -5.11% |
Main competitors
| Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 1.63B | +24.61% | +29.93% | +5.07% | +4.31% | 1.46x | ||
| 7.98B | +9.74% | +13.98% | +6.52% | +3.82% | 0.46x | ||
| 14.98B | +9.06% | +20.36% | +32.01% | +5.22% | 3.45x | ||
| 1.83B | -24.08% | -15.43% | - | -11.94% | 0.17x | ||
| 6.85B | -68.84% | -61.90% | -28.59% | -21.29% | 2.38x | ||
| 8.12B | +7.54% | +19.31% | +6.90% | +3.58% | 2x | ||
| 2.33B | +42.31% | +50.91% | +18.27% | +14.91% | -1.85x | ||
| 1.16B | +14.50% | +31.94% | +14.11% | +6.29% | 0.4x | ||
| 1.89B | +15.00% | +17.94% | +59.83% | +18.80% | -0.29x | ||
| 1.97B | +17.37% | +26.90% | +4.69% | +2.75% | 0.69x | ||
| 4.13B | +11.49% | +20.31% | +16.70% | +6.95% | 2.34x | ||
| 532M | -40.26% | - | - | - | - | ||
| 11.58M | -3,768.28% | -4,207.12% | -34.76% | -30.38% | 3.85x | ||
| 788M | -46.45% | -44.80% | -76.34% | -13.26% | 3.21x | ||
| 686M | +19.38% | +22.41% | +9.00% | - | -1.79x | ||
| 1.04B | +27.44% | +35.35% | +9.95% | +7.09% | -1.51x | ||
| 249M | -203.30% | -194.99% | -157.13% | - | 0.99x | ||
| 1.66B | +21.39% | +24.90% | +21.69% | +11.88% | -1.07x | ||
| Average | 3.21B | -218.41% | -247.65% | -5.75% | +0.58% | 0.88x | |
| Weighted average by Cap. | 5.54B | -89.72% | -93.61% | +4.13% | +0.10% | 1.25x |
- Stock Market
- Equities
- A068270 Stock
- Sector Celltrion, Inc.
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition